37524 Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 

Controlled substance Drug code Schedule 

Cocaine .................................................................................................................................................................... 9041 II 

Codeine .................................................................................................................................................................... 9050 II 

Etorphine HCl .......................................................................................................................................................... 9059 II 

Dihydrocodeine ........................................................................................................................................................ 9120 II 

Oxycodone ............................................................................................................................................................... 9143 II 

Hydromorphone ....................................................................................................................................................... 9150 II 

Diphenoxylate .......................................................................................................................................................... 9170 II 

Ecgonine .................................................................................................................................................................. 9180 II 

Ethylmorphine .......................................................................................................................................................... 9190 II 

Hydrocodone ............................................................................................................................................................ 9193 II 

Levomethorphan ...................................................................................................................................................... 9210 II 

Levorphanol ............................................................................................................................................................. 9220 II 

Isomethadone .......................................................................................................................................................... 9226 II 

Meperidine ............................................................................................................................................................... 9230 II 

Meperidine intermediate-A ....................................................................................................................................... 9232 II 

Meperidine intermediate-B ....................................................................................................................................... 9233 II 

Meperidine intermediate-C ...................................................................................................................................... 9234 II 

Methadone ............................................................................................................................................................... 9250 II 

Methadone intermediate .......................................................................................................................................... 9254 II 

Metopon ................................................................................................................................................................... 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II 

Morphine .................................................................................................................................................................. 9300 II 

Thebaine .................................................................................................................................................................. 9333 II 

Dihydroetorphine ...................................................................................................................................................... 9334 II 

Levo-alphacetylmethadol ......................................................................................................................................... 9648 II 

Oxymorphone .......................................................................................................................................................... 9652 II 

Noroxymorphone ..................................................................................................................................................... 9668 II 

Phenazocine ............................................................................................................................................................ 9715 II 

Thiafentanil .............................................................................................................................................................. 9729 II 

Piminodine ............................................................................................................................................................... 9730 II 

Racemethorphan ..................................................................................................................................................... 9732 II 

Racemorphan .......................................................................................................................................................... 9733 II 

Alfentanil .................................................................................................................................................................. 9737 II 

Remifentanil ............................................................................................................................................................. 9739 II 

Sufentanil ................................................................................................................................................................. 9740 II 

Carfentanil ................................................................................................................................................................ 9743 II 

Tapentadol ............................................................................................................................................................... 9780 II 

Bezitramide .............................................................................................................................................................. 9800 II 

Fentanyl ................................................................................................................................................................... 9801 II 

Moramide-intermediate ............................................................................................................................................ 9802 II 

The company plans to manufacture 

small quantities of the listed controlled 

substances in bulk for distribution to its 

customers. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16468 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Cody Laboratories Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before August 31, 2018. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before August 31, 

2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and request for hearing on 

applications to import narcotic raw 

material are not appropriate. 72 FR 3417 

(January 25, 2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 

20, 2018, Cody Laboratories, Inc., Steve 

Hartman, 601 Yellowstone Avenue, 

Cody, Wyoming 82414–9221 applied to 

be registered as an importer of the 

following basic classes of controlled 

substances: 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 37525 

Controlled substance Drug 

code Schedule 

Phenylacetone ................ 8501 II 

Poppy Straw Concentrate.9670 II 

Tapentadol ...................... 9780 II 

The company plans to import narcotic 

raw materials to manufacture bulk 

controlled substances for distribution to 

its customers. The company plans to 

import an intermediate form of 

tapentadol (9780), to bulk manufacture 

tapentadol for distribution to its 

customers. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16467 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Galephar Pharmaceutical 

Research Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 31, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 31, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

delegated to the Assistant Administrator 

of the DEA Diversion Control Division 

(‘‘Assistant Administrator’’) pursuant to 

section 7 of 28 CFR part 0, appendix to 

subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on July 3, 

2018, Galephar Pharmaceutical 

Research Inc., #100 Carr 198 Industrial 

Park, Juncos, Puerto Rico 00777 applied 

to be registered as an importer of the 

following basic class of controlled 

substance: 

Controlled substance Drug 

code Schedule 

Hydromorphone .............. 9150 II 

The company plans to import the 

listed controlled substance in finished 

dosage form for clinical trials, research 

and analytical purposes. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16466 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Ultra Scientific Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 31, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 31, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on April 

4, 2018, Ultra Scientific Inc., 250 Smith 

Street, North Kingstown, Rhode Island 

02852 applied to be registered as an 

importer of the following basic classes 

of controlled substances: 

Controlled substance Drug 

code Schedule 

Marihuana ....................... 7360 I 

Tetrahydrocannabinols ... 7370 I 

The company plans to import 

derivatives of the listed controlled 

substances for use as chemical 

standards for testing and calibration 

only of analytical equipment. The above 

controlled substances will not be 

imported for human or animal 

consumption. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16465 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Anderson Brecon, Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 


sradovich on DSK3GMQ082PROD with NOTICES